An adjuvant developed with funding from the National Institutes of Health (NIH) has contributed to the success of the Covaxin COVID-19 vaccine, which roughly 25 million people have already received in India and elsewhere.
Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance a vaccine’s effectiveness. Covaxin was developed and is manufactured in India by Bharat Biotech, stated the NIH on June 29, 2021.
U.S. NIH Turbo Charges India’s COVID-19 Vaccine
Can Genetics Tackle COVID-19 with Drug Repurposing
Each SARS-CoV-2 betacoronavirus infection has variable severities in people, ranging from asymptomatic to severe life-threatening respiratory failure, coagulation, or neurological symptoms, among other sequelae, said genomics researchers in a blog posting on July 7, 2021.
These individual-level responses to infection have led scientists to investigate the effects of genetic variation in the human genome that may explain the broad spectrum of COVID-19 severity and susceptibility, continues the article.
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
mRNA From COVID-19 Vaccines Not Detectable in Breast Milk
Authors say lactating women receiving a COVID-19 vaccine do not need to stop breastfeeding
Nearly Four in 10 With Mild COVID-19 Report Symptoms Seven Months Later
Fatigue remains the most common symptom among otherwise healthy people
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Authors say patients even with COVID-19 should continue taking cardiovascular drugs as prescribed
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
Pfizer cited data from Israel showing the vaccine is declining in effectiveness as the highly contagious Delta variant circulates